/HSDT
HSDT Stock - Solana Company
Healthcare|Medical - DevicesNASDAQ
$2.98+3.11%
+$0.09 (+3.11%) • Dec 19
50
GoAI Score
GoAI Score
Weighted average: Momentum (25%) + Sentiment (35%) + Risk (20%) + Value (20%). ≥70 = BUY, ≤35 = SELL.HOLD
Medium Confidence
Momentum
Momentum Score
Based on price vs 50-day MA (40%), 200-day MA (40%), and MA crossover (20%). Higher = stronger uptrend.0
Sentiment
Sentiment Score
Based on analyst price target upside. 50 = neutral, 100 = very bullish (25%+ upside expected).70
Risk Score
Risk Score
Based on stock beta (volatility). Higher score = lower risk. Red (<40) = high volatility, Green (>60) = stable.79
Price Target
Price Target
Average analyst price target from the last quarter. Shows expected upside/downside from current price.+10.0%upside
Target: $3.28
AI Analysis PreviewPremium
Real-time AI-powered market analysis
Precise entry/exit price targets
Risk assessment & position sizing
Unlock GoAI Insights for HSDT
Get institutional-grade AI analysis, real-time signals, and deep market intelligence powered by advanced machine learning.
Buy/Sell Signals
94% win rate on Alpha signals
Deep Analysis
Institutional-grade thesis
Real-Time Alerts
SMS & push notifications
Risk Scoring
Multi-factor analysis
Free 14-day trial • No credit card required
Active Trade Setup
ENTRY ZONE$2.95 – $3.01
TARGET (TP)$3.43
STOP LOSS$2.74
RISK/REWARD1:1.9
Premium members get real-time SMS alerts
Price Chart
Financial Statements
Revenue & Profitability Trend
← Swipe to see more →
Revenue
Net Income (Profit)
Net Loss
Key Metrics
Market CapN/A
P/E RatioN/A
Beta1.03
52W High$1200.00
52W Low$2.62
Avg VolumeN/A
Income Statement (Fiscal Year)
| Metric | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 |
|---|---|---|---|---|---|
| Revenue | $520,000 | $644,000 | $787,000 | $522,000 | $661,000 |
| Gross Profit | $-62,000 | $61,000 | $324,000 | $224,000 | $-90,000 |
| Gross Margin | -11.9% | 9.5% | 41.2% | 42.9% | -13.6% |
| Operating Income | $-13,903,000 | $-12,428,000 | $-15,516,000 | $-18,142,000 | $-14,076,000 |
| Net Income | $-11,742,000 | $-8,850,000 | $-14,072,000 | $-18,132,000 | $-14,130,000 |
| Net Margin | -2258.1% | -1374.2% | -1788.1% | -3473.6% | -2137.7% |
| EPS | $-4.33 | $-7.28 | $-26.06 | $-184.51 | $-294.93 |
Company Overview
Solana Co. is a neurotech company in the medical device industry that focuses on neurological wellness. The firm develops, licenses and acquires non-invasive platform technologies that amplify the brain’s ability to heal itself and reduce symptoms of neurological disease or trauma. It engages in the development of the investigational portable neuromodulation stimulator, that delivers neurostimulation via the tongue which has been shown in clinical studies to enhance the effectiveness of physical exercises in people with neurological symptoms from disease or trauma such as mild-to-moderate traumatic brain injury. The company was founded on March 13, 2014 and is headquartered in Newtown, PA.
Visit WebsiteLoading analyst ratings...
Earnings History & Surprises
HSDTBeat Rate
47%
Last 19 quarters
Avg Surprise
-999.6%
EPS vs Estimate
Beats / Misses
9/10
Last 12 quarters
Latest EPS
$-32.89
Q4 2025
EPS Surprise History
Q1 24
+63.7%
$-1.47vs$-4.05
Q2 24
+20.4%
$-3.08vs$-3.87
Q3 24
-28.0%
$-0.64vs$-0.50
Q4 24
+6.6%
$-0.99vs$-1.06
Q1 25
-9.6%
$-1.03vs$-0.94
Q2 25
-4294.4%
$-382.31vs$-8.70
Q3 25
+38.0%
$-79.73vs$-128.50
Q4 25
+34.9%
$-32.89vs$-50.50
Beat Estimate
Missed Estimate
Quarterly EPS Details
| Period | Report Date | Estimated EPS | Actual EPS | Surprise | Result |
|---|---|---|---|---|---|
Q2 2026 | Apr 29, 2026 | — | — | — | — |
Q4 2025 | Nov 18, 2025 | $-50.50 | $-32.89 | +34.9% | ✓ BEAT |
Q3 2025 | Aug 14, 2025 | $-128.50 | $-79.73 | +38.0% | ✓ BEAT |
Q2 2025 | May 1, 2025 | $-8.70 | $-382.31 | -4294.4% | ✗ MISS |
Q1 2025 | Mar 25, 2025 | $-0.94 | $-1.03 | -9.6% | ✗ MISS |
Q4 2024 | Nov 12, 2024 | $-1.06 | $-0.99 | +6.6% | ✓ BEAT |
Q3 2024 | Aug 12, 2024 | $-0.50 | $-0.64 | -28.0% | ✗ MISS |
Q2 2024 | May 13, 2024 | $-3.87 | $-3.08 | +20.4% | ✓ BEAT |
Q1 2024 | Mar 28, 2024 | $-4.05 | $-1.47 | +63.7% | ✓ BEAT |
Q4 2023 | Nov 9, 2023 | $-6.00 | $-5.49 | +8.5% | ✓ BEAT |
Q3 2023 | Aug 10, 2023 | $-5.50 | $-3.00 | +45.5% | ✓ BEAT |
Q2 2023 | May 11, 2023 | $-5.00 | $-4.50 | +10.0% | ✓ BEAT |
Q1 2023 | Mar 9, 2023 | $-5.50 | $-8.50 | -54.5% | ✗ MISS |
Q4 2022 | Nov 14, 2022 | $-12.00 | $-6.00 | +50.0% | ✓ BEAT |
Q3 2022 | Aug 15, 2022 | $-1.12 | $-48.50 | -4230.4% | ✗ MISS |
Q2 2022 | May 12, 2022 | $-1.13 | $-57.50 | -4988.5% | ✗ MISS |
Q1 2022 | Mar 14, 2022 | $-1.16 | $-65.50 | -5546.6% | ✗ MISS |
Q4 2021 | Nov 10, 2021 | $-87.50 | $-100.50 | -14.9% | ✗ MISS |
Q3 2021 | Aug 12, 2021 | $-76.50 | $-129.00 | -68.6% | ✗ MISS |
Q2 2021 | May 17, 2021 | $-61.00 | $-82.50 | -35.2% | ✗ MISS |
Latest News
Helius Medical Tech Q3 EPS $(32.89) Beats $(50.50) Estimate, Sales $697.000K Beat $110.000K Estimate
📈 PositiveBenzinga•Nov 18, 2025, 09:06 PM
Solana Company Intends To Tokenize HSDT Shares On Superstate's Opening Bell Platform
📈 PositiveBenzinga•Nov 12, 2025, 01:33 PM
Solana shares are trading higher after the company announced a $100 million buyback plan.
📈 PositiveBenzinga•Nov 5, 2025, 05:23 PM
Reported Earlier: Solana Announces New $100M Buyback Plan
📈 PositiveBenzinga•Nov 5, 2025, 03:36 PM
Solana Company Announces It Has Applied To Canadian Securities Regulators For An Order To Cease Being A Reporting Issuer In All Canadian Jurisdictions
➖ NeutralBenzinga•Nov 4, 2025, 09:21 PM
CORRECTION FROM SOURCE: Solana Adds 0.1M SOL Since October, Now Holds Over 2.3M SOL And $15M Of Cash And Stablecoins To Accelerate Digital Asset Strategy
📈 PositiveBenzinga•Oct 29, 2025, 04:24 PM
Solana Adds 1M SOL Since October, Now Holds Over 2.3M SOL And $15M Of Cash And Stablecoins To Accelerate Digital Asset Strategy
📈 PositiveBenzinga•Oct 29, 2025, 01:37 PM
Solana Company Partners With Helius And Twinstake For Non-Custodial Staking Services, Stakes SOL Via Anchorage Digital
📈 PositiveBenzinga•Oct 23, 2025, 01:11 PM
Helius Medica Now Holds 2.2M SOL
➖ NeutralBenzinga•Oct 6, 2025, 12:07 PM
Helius Medical Rebrands As Solana Company, Partners With Solana Foundation To Advance On-Chain Growth And SOL-Focused Strategy
📈 PositiveBenzinga•Sep 29, 2025, 12:18 PM
Helius Files FDA Submission Seeking PoNS Device Expansion To Treat Gait And Balance Deficits In Stroke Patients
📈 PositiveBenzinga•Sep 25, 2025, 11:10 AM
Helius Medical Acquires 760K+ Solana Tokens At $231 Avg, Holds In Excess Of $335M Of Cash To Be Used To Further Digital Asset Treasury Strategy
📈 PositiveBenzinga•Sep 22, 2025, 11:04 AM
Helius Medical Technologies shares are trading higher after the company announced the launch of a $1.25 billion SOL-backed treasury strategy with an oversubscribed PIPE offering at $6.88 per share and $10.13 warrants.
📈 PositiveBenzinga•Sep 15, 2025, 01:23 PM
Helius Medical Technologies Announces It May Offer And Sell Shares Of Common Stock Of Up To $92.8M From Time To Time
➖ NeutralBenzinga•Sep 15, 2025, 01:00 PM
Helius announces over $500 million in funding to launch SOL treasury company
📈 PositiveSeeking Alpha•Sep 15, 2025, 12:40 PM
Helius Launches $1.25B SOL-Backed Treasury Strategy With Oversubscribed PIPE Offering At $6.88 Per Share And $10.13 Warrants
📈 PositiveBenzinga•Sep 15, 2025, 12:12 PM
Helius Medical Technologies announces reverse stock split
📉 NegativeSeeking Alpha•Jun 27, 2025, 01:17 PM
Frequently Asked Questions about HSDT
What is HSDT's current stock price?
Solana Company (HSDT) is currently trading at $2.98 per share. The stock has moved +3.11% today.
What is the analyst price target for HSDT?
No analyst price targets are currently available for this stock.
What sector is Solana Company in?
Solana Company operates in the Healthcare sector, specifically within the Medical - Devices industry. The company is traded on the NASDAQ exchange.
What is HSDT's market cap?
Solana Company has a market capitalization of $0.12 billion, making it a small-cap company.
Does HSDT pay dividends?
No, Solana Company does not currently pay a dividend to shareholders.
Similar Stocks
Healthcare SectorCATX
Perspective Therapeutics, Inc.
$2.75
Mkt Cap: $0.2B
ELMD
Electromed, Inc.
$28.62
Mkt Cap: $0.2B
INFU
InfuSystem Holdings, Inc.
$9.20
Mkt Cap: $0.2B
INGN
Inogen, Inc.
$6.71
Mkt Cap: $0.2B
NNOX
Nano-X Imaging Ltd.
$2.99
Mkt Cap: $0.2B
OM
Outset Medical, Inc.
$3.70
Mkt Cap: $0.1B
PROF
Profound Medical Corp.
$7.63
Mkt Cap: $0.2B
QTRX
Quanterix Corporation
$6.59
Mkt Cap: $0.3B
SNWV
SANUWAVE Health, Inc.
$32.25
Mkt Cap: $0.3B
TLSI
TriSalus Life Sciences, Inc.
$7.42
Mkt Cap: $0.2B
Explore stocks similar to HSDT for comparison